In this review we analyze the cardiorenal effects of hyperuricemia and try to answer the eternal question of whether it is or is not to be considered a true risk factor in addition to a well-established marker of cardiovascular, cerebrovascular and renal risk.
KratzerJ.T., LanaspaM.A., MurphyM.N.. Evolutionary history and metabolic insights of ancient mammalian uricases.Proc Natl Acad Sci USA.2014; 111(10): 3763–8.
2.
SutinA.R., CutlerR.G., CamandolaS.. Impulsivity is associated with uric acid: evidence from humans and mice.Biol Psychiatry.2014; 75(1): 31–7.
3.
AmesB.N., CathcartR., SchwiersE., HochsteinP.Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proc Natl Acad Sci USA.1981; 78(11): 6858–62.
4.
CicerchiC., LiN., KratzerJ.. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.FASEB J.2014; 28(8): 3339–50.
5.
KandaE., MuneyukiT., KannoY., SuwaK., NakajimaK.Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study.PLoS One.2015; 10(2): e0118031.
6.
FuS., LuoL., YeP., XiaoW.Epidemiological associations between hyperuricemia and cardiometabolic risk factors: a comprehensive study from Chinese community.BMC Cardiovasc Disord.2015; 15: 129.
7.
WangJ., QinT., ChenJ., LiY., WangL., HuangH., LiJ.Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies.PLoS One.2014; 9(12): e114259.
MesserliF.H., FrohlichE.D., DreslinskiG.R., SuarezD.H., AristimunoG.G.Serum uric acid in: an indicator of renal vascular involvement.Ann Intern Med.1980; 93(6): 817–21.
10.
ChoiH.K., SorianoL.C., ZhangY., RodriguezL.A.G.Antihypertensive drugs and risk of incident gout among patients with hypertension.BMJ.2012; 344: d8190.
11.
MikulsT., FarrarJ.T., BilkerW.B., FernandesS., SchumacherH.R.Jr., SaagK.G.Gout epidemiology: results from the UK General Practice Research Database, 1990–1999.Ann Rheum Dis.2005; 64(2): 267–72.
12.
MiaoY., OttenbrosS.A., LavermanG.D.. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist.Hypertension.2011; 58(1): 2–7.
13.
HoleggenA., AldermanM.H., KjeldsenS.E.. The impact of serum uric acid on cardiovascular outcomes in.Kidney Int.2004; 65(3): 1041–9.
14.
SzwejkowskiB.R., GandyS.J., RekhrajS.. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.J Am Col Cardiol.2013; 62(24): 2284–93.
15.
KaoM.P., AngD.S., GandyS.J.Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease.J Am Soc Nephrol.2011; 22(7): 1382–9.
16.
NomanA., AngD.S., OgstonS., LangC.C., StruthersA.D.Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.Lancet.2010; 375(9732): 2161–7.
17.
NomuraJ., BussoN., IvesA.. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.Sci Rep.2014; 4: 4554.
18.
NomuraJ., BussoN., IvesA.. Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.PLoS One.2013; 8(9): e75527.
19.
KangD.H., NakagawaT., FengL.. A role for.J Am Soc Nephrol.2002; 13: 2888–97.
20.
KimS.Y., GuevaraJ.P., KimK.M., ChoiH.K., HeitjanD.F., AlbertD.A.: a systematic review and meta-analysis.Arthritis Rheum.2009; 61: 885–92.
21.
GraysonP.C., KimS.Y., LavalleyM., ChoiH.K.: a systematic review and meta-analysis.Arthritis Care Res (Hoboken).2011; 63(1): 102–10.
22.
KodamaS., SaitoK., YachiY.. Association between serum uric acid and development of.Diabetes Care.2009; 32: 1737–42.
23.
NakagawaT., HuH., ZharikovS.. A causal role for uric acid in.Am J Physiol Renal Physiol.2006; 290(3): F625–31.
24.
WheelerJ.G., JuzwishinK.D., EiriksdottirG., GudnasonV., DaneshJ.Serum uric acid and in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.PLoS Med.2005; 2(3): e76.
25.
StrasakA.M., KelleherC.C., BrantL.J.. VHM&PP study group. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.Int J Cardiol.2008; 125(2): 232–9.
WangH., JacobsD.R.Jr., GaffoA.L., GrossM.D., GoffD.C.Jr., CarrJ.J.Serum urate and incident cardiovascular disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.PLoS One.2015; 10(9): e0138067.
29.
PiepoliM.F., HoesA.W., AgewallS..; Authors/Task Force Members. 2016European Guidelines on cardiovascular disease prevention in clinical practice.Eur Heart J. 2016.
